688796 百奥赛图
已收盘 09-04 15:00:00
资讯
新帖
简况
百奥赛图-B(02315.HK)获富国基金增持95万股
中金财经 · 09-04 22:47
百奥赛图-B(02315.HK)获富国基金增持95万股
9月4日百奥赛图跌5.66%，富国精准医疗混合A基金重仓该股
证券之星 · 09-04 16:36
9月4日百奥赛图跌5.66%，富国精准医疗混合A基金重仓该股
百奥赛图与齐鲁制药达成全人纳米抗体分子非排他授权合作，支持神经领域创新药物开发
美通社 · 09-03 14:23
百奥赛图与齐鲁制药达成全人纳米抗体分子非排他授权合作，支持神经领域创新药物开发
百奥赛图与齐鲁制药达成非独家授权协议，共推神经科学领域创新药物研发
美股速递 · 09-02 20:01
百奥赛图与齐鲁制药达成非独家授权协议，共推神经科学领域创新药物研发
港股异动 | 百奥赛图-B(02315)涨超13% 上半年核心业务维持高速增长 AI赋能加速平台兑现
智通财经 · 09-02
港股异动 | 百奥赛图-B(02315)涨超13% 上半年核心业务维持高速增长 AI赋能加速平台兑现
百奥赛图（688796）披露2026年半年度业绩说明会公告，9月1日股价上涨3.66%
证券之星 · 09-01
百奥赛图（688796）披露2026年半年度业绩说明会公告，9月1日股价上涨3.66%
富国基金管理有限公司增持百奥赛图(02315)53.6万股 每股作价约60.17港元
智通财经 · 09-01
富国基金管理有限公司增持百奥赛图(02315)53.6万股 每股作价约60.17港元
每周股票复盘：百奥赛图（688796）H1营收增51.6%，净利增402.29%
证券之星 · 08-30
每周股票复盘：百奥赛图（688796）H1营收增51.6%，净利增402.29%
百奥赛图（688796）2026年中报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 08-29
百奥赛图（688796）2026年中报简析：营收净利润同比双双增长，应收账款上升
百奥赛图（688796）披露2026年半年度报告，8月28日股价下跌3.94%
证券之星 · 08-28
百奥赛图（688796）披露2026年半年度报告，8月28日股价下跌3.94%
百奥赛图2026年半年度业绩：“双引擎”全速兑现 规模化盈利持续放大
同花顺 · 08-28
百奥赛图2026年半年度业绩：“双引擎”全速兑现 规模化盈利持续放大
股市必读：百奥赛图新发布《百奥赛图（北京）医药科技股份有限公司2026年第三次临时股东会会议资料》
证券之星 · 08-28
股市必读：百奥赛图新发布《百奥赛图（北京）医药科技股份有限公司2026年第三次临时股东会会议资料》
图解百奥赛图中报：第二季度单季净利润同比增长123.79%
证券之星 · 08-28
图解百奥赛图中报：第二季度单季净利润同比增长123.79%
百奥赛图-B(02315)发布中期业绩，股东应占盈利2.41亿元，同比增长402.3%
智通财经 · 08-27
百奥赛图-B(02315)发布中期业绩，股东应占盈利2.41亿元，同比增长402.3%
8月24日百奥赛图跌6.94%，富国精准医疗混合A基金重仓该股
证券之星 · 08-24
8月24日百奥赛图跌6.94%，富国精准医疗混合A基金重仓该股
8月19日百奥赛图跌6.65%，富国精准医疗混合A基金重仓该股
证券之星 · 08-19
8月19日百奥赛图跌6.65%，富国精准医疗混合A基金重仓该股
8月17日百奥赛图跌5.17%，富国精准医疗混合A基金重仓该股
证券之星 · 08-17
8月17日百奥赛图跌5.17%，富国精准医疗混合A基金重仓该股
8月13日百奥赛图涨10.22%，富国精准医疗混合A基金重仓该股
证券之星 · 08-13
8月13日百奥赛图涨10.22%，富国精准医疗混合A基金重仓该股
8月10日百奥赛图涨5.29%，富国精准医疗混合A基金重仓该股
证券之星 · 08-10
8月10日百奥赛图涨5.29%，富国精准医疗混合A基金重仓该股
股市必读：百奥赛图新发布《百奥赛图（北京）医药科技股份有限公司2026年半年度业绩预告的自愿性披露公告》
证券之星 · 08-10
股市必读：百奥赛图新发布《百奥赛图（北京）医药科技股份有限公司2026年半年度业绩预告的自愿性披露公告》
加载更多
公司概况
公司名称：
百奥赛图(北京)医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2025-12-10
主营业务：
百奥赛图(北京)医药科技股份有限公司的主营业务是CRO行业细分领域中的临床前CRO，以及抗体药物的研发。公司的主要产品是基因编辑服务、创新模式动物销售、临床前药理药效评价服务、抗体开发、创新药合作研发。
发行价格：
26.68
{"stockData":{"symbol":"688796","market":"SH","secType":"STK","nameCN":"百奥赛图","latestPrice":119.89,"timestamp":1788505200000,"preClose":127.08,"halted":0,"volume":2552957,"delay":0,"changeRate":-0.0566,"floatShares":38607500,"shares":447000000,"eps":0.8197,"marketStatus":"已收盘","change":-7.19,"latestTime":"09-04 15:00:00","open":127,"high":127.03,"low":119.49,"amount":313000000,"amplitude":0.0593,"askPrice":119.89,"askSize":1,"bidPrice":119.88,"bidSize":12,"shortable":0,"etf":0,"ttmEps":0.8197,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"adjPreClose":127.08,"symbolType":"stock_kcb","openAndCloseTimeList":[[1788485400000,1788492600000],[1788498000000,1788505200000]],"highLimit":139.79,"lowLimit":114.37,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":446898420,"isCdr":false,"pbRate":22.13,"roa":"--","peRate":146.260827,"roe":"10.49%","epsLYR":0.43,"committee":-0.541284,"marketValue":53579000000,"turnoverRate":0.0661,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-07。","afterMarket":{"amount":154298.43,"volume":1287,"close":119.89,"buyVolume":0,"sellVolume":229,"time":1788507237746,"indexStatus":"已收盘 09-04 15:30:00","preClose":127.08},"hkstockBrief":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":60.6,"timestamp":1788509283003,"preClose":64.15,"halted":0,"volume":1631986,"delay":0,"premium":"-56.75"},"floatMarketCap":4629000000},"requestUrl":"/m/hq/s/688796","defaultTab":"news","newsList":[{"id":"2664330266","title":"百奥赛图-B(02315.HK)获富国基金增持95万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664330266","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664330266?lang=zh_cn&edition=full","pubTime":"2026-09-04 22:47","pubTimestamp":1788533225,"startTime":"0","endTime":"0","summary":"格隆汇6月4日丨根据联交所最新权益披露资料显示，2026年6月1日，百奥赛图-B(02315.HK)获富国基金管理有限公司在场内以每股均价45.1061港元增持95万股，涉资约4285.1万港元。\r\n\r\n 增持后，富国基金管理有限公司最新持股数目为666.17万股，持股比例由5.18%上升至6.01%。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/04/20260904471142.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/04/20260904471142.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260904/32360964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","02315","688796","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809353","title":"9月4日百奥赛图跌5.66%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809353","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664809353?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:36","pubTimestamp":1788511008,"startTime":"0","endTime":"0","summary":"证券之星消息，9月4日百奥赛图跌5.66%，收盘报119.89元，换手率6.61%，成交量2.55万手，成交额3.13亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.98亿元，最新净值3.3539，较上一交易日上涨1.79%，近一年下跌10.98%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400029037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664782740","title":"百奥赛图与齐鲁制药达成全人纳米抗体分子非排他授权合作，支持神经领域创新药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2664782740","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664782740?lang=zh_cn&edition=full","pubTime":"2026-09-03 14:23","pubTimestamp":1788416580,"startTime":"0","endTime":"0","summary":"北京2026年9月3日 /美通社/ -- 百奥赛图（北京）医药科技股份有限公司于2026年9月2日宣布，公司近期与齐鲁制药有限公司签署全人纳米抗体分子非排他授权合作协议。根据协议，百奥赛图将向齐鲁制药授权一款全人纳米抗体分子，用于支持其在神经领域创新药物项目中的研发探索。通过此次授权，齐鲁制药可结合其自身研发策略，对相关纳米抗体分子开展进一步研究和开发，后续项目的开发形式将根据项目特点和治疗需求灵活推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5039953_ZH39953_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5039953_ZH39953_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["06978","LNGR","01477","02315","MEDX","BK0216","BK1574","688796","BK1161","BK1191","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175705776","title":"百奥赛图与齐鲁制药达成非独家授权协议，共推神经科学领域创新药物研发","url":"https://stock-news.laohu8.com/highlight/detail?id=1175705776","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175705776?lang=zh_cn&edition=full","pubTime":"2026-09-02 20:01","pubTimestamp":1788350476,"startTime":"0","endTime":"0","summary":"百奥赛图近日宣布，与齐鲁制药签署了一项非独家授权协议。根据协议内容，百奥赛图将向齐鲁制药授权其自主研发的全人源VHH抗体，旨在支持后者在神经科学领域的创新药物开发。齐鲁制药将基于这一授权，进一步探索其在治疗神经系统疾病方面的应用可能。百奥赛图与齐鲁制药的此次合作，预计将为双方在神经科学领域的布局注入新的活力，并可能推动相关管线的快速进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664898242","title":"港股异动 | 百奥赛图-B(02315)涨超13% 上半年核心业务维持高速增长 AI赋能加速平台兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2664898242","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664898242?lang=zh_cn&edition=full","pubTime":"2026-09-02 10:41","pubTimestamp":1788316899,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B涨超13%，截至发稿，涨11.61%，报63.95港元，成交额1.03亿港元。消息面上，凭借“全人抗体库”与“靶点人源化小鼠库”双引擎的深度协同，百奥赛图不仅实现了营收与利润的全面跃升，更是连续5个季度保持盈利。报告期内，临床前板块总营收7.23亿元，同比增长57.9%，其中创新动物模型销售收入4.46亿元，同比增长62.4%，毛利率82.3%；抗体开发业务实现收入2.18亿元，同比增长33.8%，并维持了92.8%的高毛利率水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VTHR","02315","AGIX","ARTY","688796","CHAT","BK4588","QTOC","BK4585","VXUS","AIPO","BK0216","BK1161","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664852958","title":"百奥赛图（688796）披露2026年半年度业绩说明会公告，9月1日股价上涨3.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664852958","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664852958?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:11","pubTimestamp":1788271874,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，百奥赛图报收于121.32元，较前一交易日上涨3.66%，最新总市值为542.18亿元。该股当日开盘116.2元，最高122.03元，最低114.14元，成交额达4.26亿元，换手率为9.31%。近日，百奥赛图（北京）医药科技股份有限公司发布关于召开2026年半年度业绩说明会的公告。公告显示，公司将于2026年9月9日16:30-17:30通过进门财经平台以网络文字互动方式召开2026年半年度业绩说明会，介绍公司上半年经营成果及财务状况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100042508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688796","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664085571","title":"富国基金管理有限公司增持百奥赛图(02315)53.6万股 每股作价约60.17港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664085571","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664085571?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:40","pubTimestamp":1788262828,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，8月28日，富国基金管理有限公司增持百奥赛图(02315)53.6万股，每股作价60.1705港元，总金额约为3225.14万港元。增持后最新持股数目约为918.61万股，最新持股比例为8.29%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490536.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688796","02315","EWH","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663451820","title":"每周股票复盘：百奥赛图（688796）H1营收增51.6%，净利增402.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663451820","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663451820?lang=zh_cn&edition=full","pubTime":"2026-08-30 10:13","pubTimestamp":1788055987,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，百奥赛图报收于116.91元，较上周的134.24元下跌12.91%。本周关注点业绩披露要点：百奥赛图2026年上半年主营收入9.41亿元，同比上升51.6%；归母净利润2.41亿元，同比上升402.29%。百奥赛图（北京）医药科技股份有限公司于2025年12月4日完成首次公开发行，募集资金总额12.67亿元，扣除发行费用后实际募集资金净额11.44亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663926016","title":"百奥赛图（688796）2026年中报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663926016","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663926016?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:19","pubTimestamp":1787955582,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期百奥赛图发布2026年中报。截至本报告期末，公司营业总收入9.41亿元，同比上升51.6%，归母净利润2.41亿元，同比上升402.29%。按单季度数据看，第二季度营业总收入5.08亿元，同比上升36.79%，第二季度归母净利润1.37亿元，同比上升123.79%。本报告期百奥赛图应收账款上升，应收账款同比增幅达55.46%。持有百奥赛图最多的基金为富国精准医疗混合A，目前规模为28.98亿元，最新净值3.3919，较上一交易日上涨1.37%，近一年下跌3.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900010991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662067592","title":"百奥赛图（688796）披露2026年半年度报告，8月28日股价下跌3.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662067592","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662067592?lang=zh_cn&edition=full","pubTime":"2026-08-28 19:22","pubTimestamp":1787916166,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，百奥赛图报收于116.91元，较前一交易日下跌3.94%，最新总市值为522.47亿元。该股当日开盘121.06元，最高121.06元，最低116.23元，成交额达3.24亿元，换手率为7.08%。近日，百奥赛图（北京）医药科技股份有限公司披露《2026年半年度报告》。本报告期营业收入为941,388,593.84元，同比增长51.60%；利润总额为248,569,565.41元，同比增长316.93%；归属于上市公司股东的净利润为241,094,391.65元，同比增长402.29%；归属于上市公司股东的扣除非经常性损益的净利润为197,445,824.55元，同比增长591.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800045160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662805399","title":"百奥赛图2026年半年度业绩：“双引擎”全速兑现 规模化盈利持续放大","url":"https://stock-news.laohu8.com/highlight/detail?id=2662805399","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662805399?lang=zh_cn&edition=full","pubTime":"2026-08-28 11:34","pubTimestamp":1787888040,"startTime":"0","endTime":"0","summary":"本报讯 （记者许林艳）8月27日，百奥赛图（北京）医药科技股份有限公司（以下简称“百奥赛图”）发布2026年半年度报告。报告期内，该公司实现营收9.4亿元，同比增长51.6%；归母净利润2.41亿 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260828/c679383787.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260828/c679383787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662350850","title":"股市必读：百奥赛图新发布《百奥赛图（北京）医药科技股份有限公司2026年第三次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662350850","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662350850?lang=zh_cn&edition=full","pubTime":"2026-08-28 05:30","pubTimestamp":1787866234,"startTime":"0","endTime":"0","summary":"百奥赛图（北京）医药科技股份有限公司2026年度“提质增效重回报”专项行动方案的半年度评估报告2026年上半年临床前产品及服务业务收入72,349.19万元，同比增长57.94%，毛利率约75.22%；抗体发现业务收入21,785.97万元，同比增长33.77%，毛利率达92.82%；研发费用26,733.78万元，同比增长27.85%；累计签署药物合作开发协议超455项，新增超105项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800009783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","688796","09939","159938","BK0216","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662087535","title":"图解百奥赛图中报：第二季度单季净利润同比增长123.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662087535","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662087535?lang=zh_cn&edition=full","pubTime":"2026-08-28 02:12","pubTimestamp":1787854333,"startTime":"0","endTime":"0","summary":"证券之星消息，百奥赛图2026年中报显示，上半年度公司主营收入9.41亿元，同比上升51.6%；归母净利润2.41亿元，同比上升402.29%；扣非净利润1.97亿元，同比上升591.53%；其中2026年第二季度，公司单季度主营收入5.08亿元，同比上升36.79%；单季度归母净利润1.37亿元，同比上升123.79%；单季度扣非净利润1.07亿元，同比上升156.12%；负债率33.39%，投资收益-1943.77万元，财务费用4676.57万元，毛利率79.3%。财报数据概要请见下图:本文数据来源于百奥赛图2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800005891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774502","title":"百奥赛图-B(02315)发布中期业绩，股东应占盈利2.41亿元，同比增长402.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774502","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662774502?lang=zh_cn&edition=full","pubTime":"2026-08-27 16:39","pubTimestamp":1787819961,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百奥赛图-B 发布截至2026年6月30日止六个月业绩，收益9.41亿元，同比增长51.6%;公司权益股东应占盈利2.41亿元，同比增长402.3%;每股基本盈利0.54元。2026年上半年，以创新动物模型销售为核心的临床前产品与服务业务实现营业收入人民币7.235亿元，较去年同期增长57.9%，同时毛利率保持在70%以上的高水平。通过AI及自动化智造平台赋能，抗体发现业务2026年上半年实现营业收入人民币2.179亿元，较去年同期增长33.8%，毛利率约92.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","688796","BK0216","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221061","title":"8月24日百奥赛图跌6.94%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661221061?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:36","pubTimestamp":1787560571,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日百奥赛图跌6.94%，收盘报124.92元，换手率7.3%，成交量2.82万手，成交额3.6亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.98亿元，最新净值3.509，较上一交易日下跌3.83%，近一年下跌4.24%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400021966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688796","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660446301","title":"8月19日百奥赛图跌6.65%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660446301","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660446301?lang=zh_cn&edition=full","pubTime":"2026-08-19 16:52","pubTimestamp":1787129558,"startTime":"0","endTime":"0","summary":"证券之星消息，8月19日百奥赛图跌6.65%，收盘报131.6元，换手率8.04%，成交量3.1万手，成交额4.24亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.98亿元，最新净值3.613，较上一交易日下跌1.21%，近一年下跌2.56%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900028695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688796","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660829485","title":"8月17日百奥赛图跌5.17%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660829485","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660829485?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:39","pubTimestamp":1786955954,"startTime":"0","endTime":"0","summary":"证券之星消息，8月17日百奥赛图跌5.17%，收盘报140.7元，换手率12.55%，成交量4.85万手，成交额6.85亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.98亿元，最新净值3.6378，较上一交易日下跌0.22%，近一年上涨0.02%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700021111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659132769","title":"8月13日百奥赛图涨10.22%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2659132769","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659132769?lang=zh_cn&edition=full","pubTime":"2026-08-13 16:37","pubTimestamp":1786610220,"startTime":"0","endTime":"0","summary":"证券之星消息，8月13日百奥赛图涨10.22%，收盘报148.2元，换手率16.27%，成交量6.28万手，成交额9.14亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.98亿元，最新净值3.5952，较上一交易日下跌0.28%，近一年上涨0.19%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300026862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688796","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658308981","title":"8月10日百奥赛图涨5.29%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658308981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658308981?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:45","pubTimestamp":1786351517,"startTime":"0","endTime":"0","summary":"证券之星消息，8月10日百奥赛图涨5.29%，收盘报137.0元，换手率16.91%，成交量6.53万手，成交额9.1亿元。重仓百奥赛图的前十大公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000020825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658670108","title":"股市必读：百奥赛图新发布《百奥赛图（北京）医药科技股份有限公司2026年半年度业绩预告的自愿性披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658670108","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658670108?lang=zh_cn&edition=full","pubTime":"2026-08-10 01:27","pubTimestamp":1786296429,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，百奥赛图报收于130.12元，上涨13.64%，换手率11.49%，成交量4.44万手，成交额5.46亿元。公司公告汇总百奥赛图（北京）医药科技股份有限公司2026年半年度业绩预告的自愿性披露公告百奥赛图预计2026年半年度实现营业收入93,638.86万元至94,638.86万元，同比增长50.80%至52.41%；归属于母公司所有者的净利润为23,609.44万元至24,609.44万元，同比增长391.87%至412.71%；扣除非经常性损益后的净利润为19,244.58万元至20,244.58万元，同比增长574.02%至609.04%。本次业绩预告未经注册会计师审计。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1161","BK1515","159938","BK1574","09939","688796"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788594064307,"stockEarnings":[{"period":"1week","weight":0.0255},{"period":"1month","weight":0.0316},{"period":"3month","weight":0.2781},{"period":"6month","weight":0.547},{"period":"1year","weight":3.4936},{"period":"ytd","weight":1.2793}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0133},{"period":"3month","weight":-0.0242},{"period":"6month","weight":-0.0471},{"period":"1year","weight":0.0436},{"period":"ytd","weight":-0.0098}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"百奥赛图(北京)医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2025-12-10","address":"北京市大兴区中关村科技园区大兴生物医药产业基地宝参南街12号院","registeredCapital":"44689万元","survey":" 百奥赛图(北京)医药科技股份有限公司的主营业务是CRO行业细分领域中的临床前CRO，以及抗体药物的研发。公司的主要产品是基因编辑服务、创新模式动物销售、临床前药理药效评价服务、抗体开发、创新药合作研发。","listedPrice":26.68},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图(688796)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图(688796)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图,688796,百奥赛图股票,百奥赛图股票老虎,百奥赛图股票老虎国际,百奥赛图行情,百奥赛图股票行情,百奥赛图股价,百奥赛图股市,百奥赛图股票价格,百奥赛图股票交易,百奥赛图股票购买,百奥赛图股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图(688796)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图(688796)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}